Skip to main content

Substance Abuse News (Page 9)

Considerable Increases in Marijuana Use Seen in Young, Midlife Adults

WEDNESDAY, Aug. 23, 2023 – Past-year marijuana use has increased considerably among young and midlife adults, according to a report published by Monitoring the Future. Megan E. Patrick, Ph.D., from...

Gastric Bypass May Increase Risk for Nonalcohol Substance Use Disorder

MONDAY, Aug. 14, 2023 – For individuals with obesity, gastric bypass surgery is associated with an increased risk for nonalcohol substance use disorder (SUD), according to a study published online...

FDA Approves Second OTC Naloxone Spray, ReVive, for Suspected Opioid Overdose

THURSDAY, Aug. 3, 2023 – The U.S. Food and Drug Administration has approved RiVive, an over-the-counter (OTC) naloxone hydrochloride nasal spray for emergency treatment of known or suspected opioid...

Researchers Explore New Nonaddictive Means of Fighting Pain

THURSDAY, Aug. 3, 2023 – New research shows that an experimental drug fine-tuned to a specific pain pathway can ease post-surgery aches, a finding that may eventually offer an alternative to highly...

Marijuana Use by Youth: After Legalization, Education Seems to Matter

THURSDAY, Aug. 3, 2023 – After their U.S. states legalize marijuana, young adults who aren't in college are more likely than college kids to use the drug and progress to cannabis use disorder, a new...

Taking Kratom Claimed Her Son's Life. Now She and Others Are Warning of the Dangers

THURSDAY, Aug. 3, 2023 – J.D. Butler was planning a future with his girlfriend at his favorite New York City restaurant when that future came to a sudden, crushing halt. “They were planning on when s...

FDA Medwatch Alert: FDA Alerts Health Care Professionals of Risks to Patients Exposed to Xylazine in Illicit Drugs

November 8, 2022 --  Health care professionals should be cautious of possible xylazine inclusion in fentanyl, heroin, and other illicit drug overdoses, as naloxone may not be able to reverse its ...

FDA Medwatch Alert: FDA Alerts Health Care Professionals of Risks to Patients Exposed to Xylazine in Illicit Drugs

November 8, 2022 --  Health care professionals should be cautious of possible xylazine inclusion in fentanyl, heroin, and other illicit drug overdoses, as naloxone may not be able to reverse its ...

FDA Medwatch Alert: Loperamide (Imodium): Drug Safety Communication - Serious Heart Problems With High Doses From Abuse and Misuse

ISSUE: FDA is warning that taking higher than recommended doses of the common over-the-counter (OTC) and prescription diarrhea medicine loperamide (Imodium), including through abuse or misuse of the...

Ask a question

To post your own question to this support group, sign in or create an account.